ID: ALA4064341

Max Phase: Preclinical

Molecular Formula: C57H80F2N8O18P2

Molecular Weight: 1265.25

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  [3H]c1ccc(C(F)(F)[C@@H](/C=C/[C@H]2CCC(=O)N2CCCCCCC(=O)OCC)OC(=O)Cc2ccc(COC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)Nc3ccc(COC(=O)NCCCC(O)(P(=O)(O)O)P(=O)(O)O)cc3)cc2)cc1

Standard InChI:  InChI=1S/C57H80F2N8O18P2/c1-4-82-49(69)17-10-5-6-11-33-67-44(27-29-48(67)68)26-28-47(57(58,59)42-14-8-7-9-15-42)85-50(70)35-39-18-20-40(21-19-39)37-84-55(74)66-46(34-38(2)3)52(72)65-45(16-12-31-62-53(60)61)51(71)64-43-24-22-41(23-25-43)36-83-54(73)63-32-13-30-56(75,86(76,77)78)87(79,80)81/h7-9,14-15,18-26,28,38,44-47,75H,4-6,10-13,16-17,27,29-37H2,1-3H3,(H,63,73)(H,64,71)(H,65,72)(H,66,74)(H4,60,61,62)(H2,76,77,78)(H2,79,80,81)/b28-26+/t44-,45-,46-,47+/m0/s1/i7T

Standard InChI Key:  YTHMUYCYKJVXFI-HKAHDNPJSA-N

Associated Targets(non-human)

Plasma 10718 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Serum 604 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Rattus norvegicus 775804 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Liver 4264 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Bone 232 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Spleen 303 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Kidney 678 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Heart 1007 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Brain 4256 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Bone 37 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 1265.25Molecular Weight (Monoisotopic): 1264.5034AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Xie H, Chen G, Young RN..  (2017)  Design, Synthesis, and Pharmacokinetics of a Bone-Targeting Dual-Action Prodrug for the Treatment of Osteoporosis.,  60  (16): [PMID:28699744] [10.1021/acs.jmedchem.6b00951]

Source